Pathology Research and Practice

Papers
(The H4-Index of Pathology Research and Practice is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Impact of estradiol in inducing endometrial cancer using RL95-2137
Mysterious interactions between macrophage-derived exosomes and tumors; what do we know?112
Incidental early mixed epithelial and stromal tumor of the efferent testicular-ductular system of the genitourinary tract: A small case series with literature review101
Novel ganglion cell marker B3GNT6: A step forward in Hirschsprung's disease diagnosis99
Identification of DNA methylation signatures in follicular-patterned thyroid tumors82
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer79
Effects of dietary curcumin on gene expression: An analysis of transcriptomic data in mice68
Astroblastoma: A molecularly defined entity, its clinico-radiological & pathological analysis of eight cases and review of literature66
Role of artificial intelligence –based machine learning model in predicting HER2/neu gene status in breast cancer65
Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistance64
Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update63
Expression and prognostic analysis of three clones of PD-L1 antibody in colorectal cancer60
Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma59
Histological and immunohistochemical analyses of osteoclast maturation in giant cell tumor of bone58
Epigenetics in intestinal stem cells: Molecular mechanisms underpinning the guardians of homeostasis in health and aging-related senescence57
Decoding poly (RC)-binding protein 1 (PCBP1), the underrated guard at the foothill of ferroptosis56
miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay55
Luteolin: A promising modulator of apoptosis and survival signaling in liver cancer55
Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers54
Low EGR1 expression predicts poor prognosis in clear cell renal cell carcinoma54
A thorough and current study of miR-214-related targets in cancer53
Vascular mimicry: A potential therapeutic target in breast cancer52
To investigate the prognostic factors of stage Ⅰ-Ⅱ gastric cancer based on P53 mutation and tumor budding51
Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target51
Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs50
Expression of TIM-3 in transitional cell carcinoma: A comparative study of tissue and serum levels49
Encapsulated thyroid neoplasms with nuclear features of papillary carcinoma: Histological and molecular evidence that subtypes with variable extension of papillary formation may still behave favorably49
The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes49
Molecular biology of microRNA-342 during tumor progression and invasion46
P16 expression and presence of lymphoid stroma are correlated with good prognosis in mucoepidermoid carcinoma of the head and neck46
Clinical/prognostic significance of Syndecan-1 expression in invasive breast carcinoma with distant metastasis and its correlation with tumor immunity45
Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis45
Endometrial serous carcinoma with extensive squamous differentiation mimicking primary endometrial squamous cell carcinoma: Clinicopathological and molecular analysis of a case with literature review44
Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis44
DIO3OS as a potential biomarker of papillary thyroid cancer44
Decreased expression of 3-hydroxybutyrate dehydrogenase 1 is a prognostic marker and promotes tumor progression in hepatocellular carcinoma41
SOX17 expression in tumor endothelial cells in colorectal cancer and its association with favorable outcomes in patients40
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis39
Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer39
0.24982404708862